WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LYRA

Based on 2 analysts offering 12 month price targets for Lyra Therapeutics Inc.
Min Forecast
$11.00+111.13%
Avg Forecast
$11.50+120.73%
Max Forecast
$12.00+130.33%

Should I buy or sell LYRA stock?

Based on 2 analysts offering ratings for Lyra Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LYRA stock forecasts and price targets.

LYRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-25
lockedlocked$00.00+00.00%2024-03-22

1 of 1

Forecast return on equity

Is LYRA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is LYRA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LYRA revenue forecast

What is LYRA's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$1.6M+3.66%
Avg 2 year Forecast
$1.6M+3.34%
Avg 3 year Forecast
$18.4M+1,077.79%
LYRA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LYRA revenue growth forecast

How is LYRA forecast to perform vs Biotechnology companies and vs the US market?
Company
105.73%
Industry
37.64%
Market
10.1%
LYRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LYRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LYRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LYRA$5.21$11.50+120.73%Strong Buy
TERN$4.82$13.50+180.08%Buy
ATAI$1.87$10.50+461.50%Strong Buy
GUTS$6.54$18.00+175.23%Strong Buy
RENB$2.15N/AN/A
View Top Biotech Stocks

Lyra Therapeutics Stock Forecast FAQ

Is Lyra Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: LYRA) stock is to Strong Buy LYRA stock.

Out of 2 analysts, 1 (50%) are recommending LYRA as a Strong Buy, 1 (50%) are recommending LYRA as a Buy, 0 (0%) are recommending LYRA as a Hold, 0 (0%) are recommending LYRA as a Sell, and 0 (0%) are recommending LYRA as a Strong Sell.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.

What is LYRA's revenue growth forecast for 2024-2026?

(NASDAQ: LYRA) Lyra Therapeutics's forecast annual revenue growth rate of 105.73% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Lyra Therapeutics's revenue in 2024 is $1,558,000.On average, 2 Wall Street analysts forecast LYRA's revenue for 2024 to be $96,485,144, with the lowest LYRA revenue forecast at $93,796,703, and the highest LYRA revenue forecast at $99,173,584. On average, 2 Wall Street analysts forecast LYRA's revenue for 2025 to be $96,186,428, with the lowest LYRA revenue forecast at $94,991,566, and the highest LYRA revenue forecast at $97,381,290.

In 2026, LYRA is forecast to generate $1,096,286,307 in revenue, with the lowest revenue forecast at $1,096,286,307 and the highest revenue forecast at $1,096,286,307.

What is LYRA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LYRA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LYRA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year LYRA price target, the average LYRA price target is $11.50, with the highest LYRA stock price forecast at $12.00 and the lowest LYRA stock price forecast at $11.00.

On average, Wall Street analysts predict that Lyra Therapeutics's share price could reach $11.50 by Mar 25, 2025. The average Lyra Therapeutics stock price prediction forecasts a potential upside of 120.73% from the current LYRA share price of $5.21.

What is LYRA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LYRA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.